HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma Clinical Trials in Shanghai, Shanghai Municipality

A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma